Yale Fillingham, MD
Orthopaedic Surgery · Bryn Mawr, PANPI 1205199346
Payments from drug & device makers
Across 738 payments — averaging $1110.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$622K
- Johnson & Johnson$91K
- Medacta USA, Inc.$81K
- Signature Orthopaedics USA Corp$9K
- Encore Medical, LP$8K
- Exactech, Inc.$4K
- plus $6K from 7 others
Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medacta USA, Inc.$5K
What the payments were for
- Consulting fees$341,96246%
- Travel & lodging$65,8269%
- Food & beverage$17,7452%
- Education$322,50043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 573 | $621,757 |
| Johnson & Johnson(3 entities) | 46 | $90,539 |
| Medacta USA, Inc. | 75 | $81,199 |
| Signature Orthopaedics USA Corp | 1 | $9,000 |
| Encore Medical, LP | 13 | $7,654 |
| Exactech, Inc. | 5 | $3,548 |
| Synthes USA Products LLC | 2 | $2,194 |
| Medical Device Business Services, Inc. | 1 | $1,740 |
| Stryker | 14 | $1,548 |
| Smith+Nephew | 5 | $433 |
| Trilliant Surgical LLC. | 1 | $147 |
| Solventum Corporation | 1 | $17 |
| Davol Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxford$208,261
- Arcos$110,453
- Persona$95,240
- STRATAFIX$91,515
- G7$86,189
- VICRYL$85,947
- Avenir$85,188
- AMISTEM$32,658
- QUADRA$18,402
- OXFORD PARTIAL KNEE$11,250
- ROSA$6,751
- ALTEON$3,500
- DERMABOND Portfolio$3,480
- Quadra C Femoral Stems$3,150
- NA$2,175
- DERMABOND$1,740
- AMIStem H Femoral Stems$1,575
- M-VIZION$1,400
- TRIATHLON$711
- Affixus$689
How this compares
$819,791 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 124 | $812 |
| Ondansetron OdtOndansetron | 79 | $803 |
| Meloxicam | 106 | $229 |
| Diclofenac Sodium | 15 | $169 |
| Tramadol Hcl | 25 | $160 |
| Amoxicillin | 45 | $52 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bryn Mawr
- Jess LonnerBryn Mawr$8.1M
- Gerald WilliamsBryn Mawr$6.8M
- Mark KurdBryn Mawr$233K
- William HozackBensalem$10.6M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Selene ParekhBensalem$4.9M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.